Get 40% Off
🚨 Volatile Markets? Find Hidden Gems for Serious Outperformance
Find Stocks Now

Palantir maintains stock $5 target despite Army contract

EditorNatashya Angelica
Published 03/06/2024, 01:13 PM
© Reuters.

On Wednesday, RBC Capital maintained its Underperform rating and $5.00 stock price target on shares of Palantir Technologies Inc . (NYSE:PLTR), despite the company securing a significant contract with the U.S. Army. Palantir's stock saw an 11% intraday increase compared to the 1% rise in the iShares Expanded Tech-Software Sector ETF (IGV).

The contract, valued at approximately $178.4 million, is for the next prototype phase of the Army's TITAN program. This phase aims to provide the Army with an AI/ML-enabled predictive capability, which is expected to be the Army's first AI-defined vehicle.

Despite this development, RBC Capital suggests the contract's value was likely already factored into Palantir's guidance for 2024, leading to questions about the stock's movement.

Palantir, in collaboration with Raytheon (NYSE:RTN), was previously awarded a $36 million contract in July 2022 to develop a prototype for the TITAN program, which is a ground intelligence system incorporating artificial intelligence and machine learning. The recent announcement confirms Palantir as the sole participant for the next phase, with the contract spread over two years, equating to $89.2 million annually.

The contract covers the development of 10 TITAN prototypes and lays the groundwork for Palantir to integrate sensor data with the Army's systems. Palantir has mentioned this as one of the significant government programs it is involved in, alongside others like CD-1, AIDP, Vantage, and JADC2.

The deal, initially anticipated in 2023, underscores Palantir's ongoing relationship with government defense programs.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Latest comments

5 ? R u on drug? Sell me at 10 then
RBC - Rich Boys Club
The analysts are stupid Fu&samd or theives (with Ives and a few others being the exception).
what do they smoke at RBC ?
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.